Hemorheology, plasma protein composition and von Willebrand Factor in type I diabetic nephropathy

被引:0
|
作者
Zimmermann, J
Schramm, L
Wanner, C
Mulzer, E
Henrich, HA
Langer, R
Heidbreder, E
机构
[1] UNIV WURZBURG,DEPT MED,D-97080 WURZBURG,GERMANY
[2] UNIV WURZBURG,DEPT SURG,D-97080 WURZBURG,GERMANY
[3] UNIV WURZBURG,DIV EXPT SURG,D-97080 WURZBURG,GERMANY
关键词
nephropathy; hemorheology; blood viscosity; plasma viscosity; erythrocyte aggregation; erythrocyte deformability; fibrinogen; von Willebrand Factor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with IDDM, especially those with albuminuria are at high risk for macrovascular and microvascular complications. Besides the major classic risk factors altered hemorheology may also play a role. Plasma viscosity, erythrocyte aggregation and erythrocyte deformability are the major determinants of blood flow in the microcirculation. Therefore, these hemorheological parameters and plasma protein composition were evaluated in 58 IDDM-patients with none (N0), incipient (N1: albuminuria 30-300 mg/day) and overt clinical nephropathy (N2: albuminuria >300 mg/day). As an estimate of endothelial injury plasma levels of von Willebrand Factor (vWF) were investigated. Patients with incipient and clinical nephropathy exhibited increasing blood levels of fibrinogen (N0=2.47+/-0.09, N1=2.71+/-0.15, N2=3.49+/-0.24 g/l, p <0.001), alpha(2)-macroglobulin (N0=257+/-11, N1=251+/-21, N2=382+/-43 mg/100 ml, p <0.01) and haptoglobin (N0=174+/-16, N1=216+/-39, N2=278+/-36 mg/100 ml, p <0.05), whereas serum albumin concentration decreased (N0=5.1+/-0.1, N1=4.7+/-0.1, N2=4.1+/-0.2 g/100 ml, p <0.001). In the same patients erythrocyte aggregation (N0=10.0+/-0.4, N1=12.1+/-0.5, N2=12.9+/-0.6, p <0.001), plasma viscosity (N0=1.34+/-0.01, N1=1.38+/-0.02, N2=1.40+/-0.02 mPas, p <0.05) and erythrocyte rigidity (N0=0.05+/-0.01, N1=0.15+/-0.05, N2=0.09+/-0.02, p <0.05) were increased, predominantly in those with overt clinical nephropathy. Erythrocyte aggregation was positively correlated with plasma concentrations of fibrinogen (r=0.65, p <0.001) and alpha(2)-macroglobulin (r=0.35, p <0.05), but negatively with plasma albumin concentration (r=-0.49, p <0.001). Plasma viscosity was positively correlated with plasma concentrations of fibrinogen (r=0.46, p <0.001) and haptoglobin (r=0.46, p <0.001). Von Willebrand Factor levels were higher in patients with overt clinical nephropathy (N0=126+/-8, N1=136+/-12, N2=163+/-14%, p <0.09, P-N0-N2 <0.05). A significant correlation between vWF and the rheological determinants could not be detected. These data demonstrate that blood rheology is profoundly altered in patients with IDDM and nephropathy. Elevated levels of vWF may indicate endothelial damage, and changes in plasma viscosity as well as erythrocyte aggregability seem to be the result of altered plasma protein composition due to proteinuria. These abnormalities in hemorheology may be an aggravating factor promoting microvascular and macrovascular damage in patients with type I diabetes mellitus and nephropathy.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [31] The Y/C1584 mutation of von Willebrand factor in type 2M von willebrand disease: frequency and clearance of von Willebrand factor
    Millar, CM
    Riddel, AF
    Griffioe, A
    Jenkin, PV
    Brown, SA
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 462 - 463
  • [32] Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor
    Peyvandi, Flora
    Kouides, Peter
    Turecek, Peter L.
    Dow, Edward
    Berntorp, Erik
    BLOOD REVIEWS, 2019, 38
  • [33] Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations
    Millar, Carolyn M.
    Riddell, Anne F.
    Brown, Simon A.
    Starke, Richard
    Mackie, Ian
    Bowen, Derrick J.
    Jenkins, P. Vincent
    van Mourik, Jan A.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 916 - 924
  • [34] Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S
    Leitner, Gerda C.
    Schmetterer, Leopold
    Kapiotis, Stylianos
    Jilma, Bernd
    THROMBOSIS RESEARCH, 2010, 125 (01) : E5 - E8
  • [35] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [36] Endothelin-1, nitric oxide and von Willebrand factor in hypertensive type 2 diabetic patients
    Ouviña, SM
    Palmer, L
    Sassetti, B
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2004, 38 (04): : 471 - 476
  • [37] The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease
    Seaman, Craig D.
    Ragni, Margaret V.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (03) : 434 - 438
  • [38] Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
    Casonato, Alessandra
    Galletta, Eva
    Galvanin, Federico
    Daidone, Viviana
    EJHAEM, 2021, 2 (03): : 340 - 348
  • [39] An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma
    Vinholt, Pernille J.
    Overgaard, Martin
    Diederichsen, Axel C. P.
    Mickley, Hans
    Poulsen, Tina S.
    Sand, Niels Peter R.
    Nybo, Mads
    Rasmussen, Lars M.
    THROMBOSIS RESEARCH, 2013, 131 (05) : 396 - 400
  • [40] Content and functional activity of von Willebrand factor in apheresis plasma
    Burnouf, T
    Caron, C
    Burkhardt, T
    Goudemand, J
    VOX SANGUINIS, 2004, 87 (01) : 27 - 33